Mapping RANKL- and OPG-expressing cells in bone tissue: the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect

Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation

David L. Lacey, Emma Timms, Hong‐Lin Tan et al. · Cell · 1998 · 5.4K citations · Full text

Inflammation, Osteoprotegerin Ligand, Sclerostin +13

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Hisataka Yasuda, Nobuyuki Shima, N. Nakagawa et al. · Proceedings of the National Academy of Sciences · 1998 · 4.2K citations · Full text

Osteoprotegerin/osteoclastogenesis-inhibitory Factor, Sclerostin, Tumor Microenvironment +14

Dictionary learning for integrative, multimodal and scalable single-cell analysis

Yuhan Hao, Tim Stuart, Madeline H. Kowalski et al. · Nature Biotechnology · 2023 · 3.9K citations · Full text

Engineering, Machine Learning, Deep Learning +11

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

Tomoki Nakashima, Mikihito Hayashi, Takanobu Fukunaga et al. · Nature Medicine · 2011 · 1.7K citations

Orthopaedic Surgery, Bone Morphogenic Protein, Bone Remodeling +8

A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia

Ninib Baryawno, Dariusz Przybylski, Monika S. Kowalczyk et al. · Cell · 2019 · 884 citations · Full text

Hematological Malignancy, Chromatin, Cell Division +9